References
- Chai-AdisaksophaCHillisCIsayamaTLimWIorioACrowtherMMortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trialsJ Thromb Haemost201513112012202026356595
- RuffCTGiuglianoRPBraunwaldEComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsLancet2014383992195596224315724
- CaldeiraDRodriguesFBBarraMNon-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysisHeart2015101151204121126037103
- HuntBJLeviMEngineering reversal – finding an antidote for direct oral anticoagulantsN Engl J Med2016375121185118627653570
- ShehabNLovegroveMCGellerAIRoseKOWeidleNJBudnitzDSUS emergency department visits for outpatient adverse drug events, 2013-2014JAMA2016316202115212527893129
- HolbrookASchulmanSWittDMEvidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 suppl152S184S
- PollackCVJrReillyPAEikelboomJIdarucizumab for dabigatran reversalN Engl J Med2015373651152026095746
- LuGDeGuzmanFRHollenbachSJA specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor XaNat Med201319444645123455714
- YehCHFredenburghJCWeitzJIThe real decoy: an antidote for factor Xa-directed anticoagulantsCirc Res2013113895495724071455
- LuGDeGuzmanFRLakhotiaSHollenbachSJPhillipsDRSinhaURecombinant antidote for reversal of anticoagulation by factor Xa inhibitorsBlood200811211983
- LuGDeGuzmanFRHollenbachSJReversal of low molecular weight heparin and fondaparinux by a recombinant antidote (r-Antidote, PRT064445)Circulation2010122suppl 21A12420
- LuGLuanPHollenbachSReconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitorsJ Thromb Haemost20097309
- HollenbachSLuGDeguzmanFCurnutteJConleyPSinhaUBolus administration of PRT064445, a recombinant factor Xa inhibitor antidote, reverses blood loss and PD markers in a rat model following enoxaparin-induced anticoagulationEur Heart J201233309310
- HollenbachSJLuGTanSPRT064445 but not recombinant Fviia reverses rivaroxaban induced anticoagulation as measured by reduction in blood loss in a rabbit liver laceration modelBlood2012120213414
- LuGLinJCurnutteJTConleyPBReversal of heparin-induced anticoagulation by andexanet alfa, a universal antidote for factor Xa inhibitorsBlood201512623232926359437
- ConnollySJMillingTJJrEikelboomJWAndexanet alfa for acute major bleeding associated with factor Xa inhibitorsN Engl J Med2016375121131114127573206
- SiegalDMCurnutteJTConnollySJAndexanet alfa for the reversal of factor Xa inhibitor activityN Engl J Med2015373252413242426559317
- QuintardHViardDDriciMDRuetschCSamamaCMIchaiCIdarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleedingThromb Haemost2017117119619727734073
- CrowtherMKittMLorenzTA phase 2 randomized, double-blind, placebo controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitorsJ Thromb Haemost201311suppl 230
- CrowtherMKittMMcClureMAbstract 10: randomized, double-blind, placebo-controlled single ascending dose pharmacokinetic and pharmacodynamic study of PRT064445, a universal antidote for factor Xa inhibitorsArterioscler Thromb Vasc Biol201333suppl 1A10
- CrowtherMLevyGGLuGA phase 2 randomized, double-blind, placebo-controlled trial demonstrating reversal of edoxaban-induced anticoagulation in healthy subjects by andexanet alfa (PRT064445), a universal antidote for factor Xa (fXa) inhibitorsBlood2014124214269
- CrowtherMLuGConleyP455: reversal of factor XA inhibitors-induced anticoagulation in healthy subjects by andexanet alfaCrit Care Med20144212A1469
- NafeeTAslamAChiGAndexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitorsExpert Rev Cardiovasc Ther201715423724528282497
- SmytheMATrujilloTFanikosJReversal agents for use with direct and indirect anticoagulantsAm J Health Syst Pharm20167310 suppl 2S27S4827147456
- LevyJHAgenoWChanNCCrowtherMVerhammePWeitzJIWhen and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTHJ Thromb Haemost201614362362726911798
- MillingTJJrKaatzSPreclinical and clinical data for factor Xa and “Universal” reversal agentsAm J Med201612911sS80S8827575436